Literature DB >> 16585544

Bruton's tyrosine kinase and SLP-65 regulate pre-B cell differentiation and the induction of Ig light chain gene rearrangement.

Rogier Kersseboom1, Van B T Ta, A J Esther Zijlstra, Sabine Middendorp, Hassan Jumaa, Pieter Fokko van Loo, Rudolf W Hendriks.   

Abstract

Bruton's tyrosine kinase (Btk) and the adapter protein SLP-65 (Src homology 2 domain-containing leukocyte-specific phosphoprotein of 65 kDa) transmit precursor BCR (pre-BCR) signals that are essential for efficient developmental progression of large cycling into small resting pre-B cells. We show that Btk- and SLP-65-deficient pre-B cells have a specific defect in Ig lambda L chain germline transcription. In Btk/SLP-65 double-deficient pre-B cells, both kappa and lambda germline transcripts are severely reduced. Although these observations point to an important role for Btk and SLP-65 in the initiation of L chain gene rearrangement, the possibility remained that these signaling molecules are only required for termination of pre-B cell proliferation or for pre-B cell survival, whereby differentiation and L chain rearrangement is subsequently initiated in a Btk/SLP-65-independent fashion. Because transgenic expression of the antiapoptotic protein Bcl-2 did not rescue the developmental arrest of Btk/SLP-65 double-deficient pre-B cells, we conclude that defective L chain opening in Btk/SLP-65-deficient small resting pre-B cells is not due to their reduced survival. Next, we analyzed transgenic mice expressing the constitutively active Btk mutant E41K. The expression of E41K-Btk in Ig H chain-negative pro-B cells induced 1) surface marker changes that signify cellular differentiation, including down-regulation of surrogate L chain and up-regulation of CD2, CD25, and MHC class II; and 2) premature rearrangement and expression of kappa and lambda light chains. These findings demonstrate that Btk and SLP-65 transmit signals that induce cellular maturation and Ig L chain rearrangement independently of their role in termination of pre-B cell expansion.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16585544     DOI: 10.4049/jimmunol.176.8.4543

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  9 in total

1.  Altered BCR signalling quality predisposes to autoimmune disease and a pre-diabetic state.

Authors:  Sebastian Königsberger; Jan Prodöhl; David Stegner; Vanessa Weis; Martin Andreas; Martin Stehling; Theresa Schumacher; Ruben Böhmer; Ina Thielmann; Judith M M van Eeuwijk; Bernhard Nieswandt; Friedemann Kiefer
Journal:  EMBO J       Date:  2012-06-22       Impact factor: 11.598

2.  Foxo3 Promotes Apoptosis of B Cell Receptor-Stimulated Immature B Cells, Thus Limiting the Window for Receptor Editing.

Authors:  Kristina Ottens; Rochelle M Hinman; Evan Barrios; Brian Skaug; Laurie S Davis; Quan-Zhen Li; Diego H Castrillon; Anne B Satterthwaite
Journal:  J Immunol       Date:  2018-06-27       Impact factor: 5.422

3.  Novel mechanism of tumor suppression by polarity gene discs large 1 (DLG1) revealed in a murine model of pediatric B-ALL.

Authors:  Gabriel J Sandoval; Daniel B Graham; Grzegorz B Gmyrek; Holly M Akilesh; Keiko Fujikawa; Benedicte Sammut; Deepta Bhattacharya; Shuba Srivatsan; Alfred Kim; Andrey S Shaw; Katherine Yang-Iott; Craig H Bassing; Eric Duncavage; Ramnik J Xavier; Wojciech Swat
Journal:  Cancer Immunol Res       Date:  2013-10-07       Impact factor: 11.151

4.  Bruton's Tyrosine Kinase Deficiency Inhibits Autoimmune Arthritis in Mice but Fails to Block Immune Complex-Mediated Inflammatory Arthritis.

Authors:  Lindsay E Nyhoff; Bridgette L Barron; Elizabeth M Johnson; Rachel H Bonami; Damian Maseda; Benjamin A Fensterheim; Wei Han; Timothy S Blackwell; Leslie J Crofford; Peggy L Kendall
Journal:  Arthritis Rheumatol       Date:  2016-08       Impact factor: 10.995

5.  Exploration of Novel Inhibitors for Bruton's Tyrosine Kinase by 3D QSAR Modeling and Molecular Dynamics Simulation.

Authors:  Rohit Bavi; Raj Kumar; Light Choi; Keun Woo Lee
Journal:  PLoS One       Date:  2016-01-19       Impact factor: 3.240

6.  IRF4 Has a Unique Role in Early B Cell Development and Acts Prior to CD21 Expression to Control Marginal Zone B Cell Numbers.

Authors:  Kristina Ottens; Anne B Satterthwaite
Journal:  Front Immunol       Date:  2021-11-22       Impact factor: 7.561

7.  Pre-B cell receptor signaling induces immunoglobulin κ locus accessibility by functional redistribution of enhancer-mediated chromatin interactions.

Authors:  Ralph Stadhouders; Marjolein J W de Bruijn; Magdalena B Rother; Saravanan Yuvaraj; Claudia Ribeiro de Almeida; Petros Kolovos; Menno C Van Zelm; Wilfred van Ijcken; Frank Grosveld; Eric Soler; Rudi W Hendriks
Journal:  PLoS Biol       Date:  2014-02-18       Impact factor: 8.029

8.  Discovery of a potent, covalent BTK inhibitor for B-cell lymphoma.

Authors:  Hong Wu; Wenchao Wang; Feiyang Liu; Ellen L Weisberg; Bei Tian; Yongfei Chen; Binhua Li; Aoli Wang; Beilei Wang; Zheng Zhao; Douglas W McMillin; Chen Hu; Hong Li; Jinhua Wang; Yanke Liang; Sara J Buhrlage; Junting Liang; Jing Liu; Guang Yang; Jennifer R Brown; Steven P Treon; Constantine S Mitsiades; James D Griffin; Qingsong Liu; Nathanael S Gray
Journal:  ACS Chem Biol       Date:  2014-03-17       Impact factor: 5.100

9.  Precursor B Cells Increase in the Lung during Airway Allergic Inflammation: A Role for B Cell-Activating Factor.

Authors:  Konstantinos Samitas; Carina Malmhäll; Madeleine Rådinger; Patricia Ramos-Ramirez; You Lu; Tünde Deák; Maria Semitekolou; Mina Gaga; Margareta Sjöstrand; Jan Lötvall; Apostolos Bossios
Journal:  PLoS One       Date:  2016-08-11       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.